Related references
Note: Only part of the references are listed.Evaluation of anticancer activity of ferrocene based benzothiazole and beta-ketooxothioacetal
Archana Ranjan et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2022)
In vitro evaluation of cytotoxicity and antimetastatic properties of novel arene ruthenium(II)-tetrazolato compounds on human cancer cell lines
Komal M. Vyas et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2021)
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Leah H. Biller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Evaluation of the Anticancer Properties of Geranyl Isovalerate, an Active Ingredient of Argyreia nervosa Extract in Colorectal Cancer Cells
Fayyaz Rasool et al.
FRONTIERS IN PHARMACOLOGY (2021)
A RuII Polypyridyl Alkyne Complex Based Metal-Organic Frameworks for Combined Photodynamic/Photothermal/Chemotherapy
Xiaochun Hu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
Ke Lin et al.
FRONTIERS IN ONCOLOGY (2020)
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways
Divya Subramonian et al.
BRITISH JOURNAL OF CANCER (2020)
The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
Cheng-Chan Yu et al.
MOLECULES (2020)
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model
Ingrid R. S. Baliza et al.
FRONTIERS IN ONCOLOGY (2019)
In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis
Jordi Pijuan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo
Mao-Chi Weng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Stimuli-Responsive Therapeutic Metallodrugs
Xiaohui Wang et al.
CHEMICAL REVIEWS (2019)
Integrating in situ formation of nanozymes with mesoporous polydopamine for combined chemo, photothermal and hypoxia-overcoming photodynamic therapy
Xiaochun Hu et al.
CHEMICAL COMMUNICATIONS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Cancer-Targeting Functionalization of Selenium-Containing Ruthenium Conjugate with Tumor Microenvironment-Responsive Property to Enhance Theranostic Effects
Zhennan Zhao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells
Maria Grazia Refolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Ke Lin et al.
FRONTIERS IN PHARMACOLOGY (2018)
Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications
Sabyasachi Chakrabortty et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
Kaja C. G. Berg et al.
MOLECULAR CANCER (2017)
Caspase-9: structure, mechanisms and clinical application
Ping Li et al.
ONCOTARGET (2017)
Patching of Lipid Rafts by Molecular Self-Assembled Nanofibrils Suppresses Cancer Cell Migration
Guanying Li et al.
CHEM (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells
Zhiqin Deng et al.
BIOMATERIALS (2017)
Functionalization of Platinum Complexes for Biomedical Applications
Xiaoyong Wang et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents
Jiangping Liu et al.
BIOMATERIALS (2015)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method-Letter
John C. Ashton
CANCER RESEARCH (2015)
The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells
Ning Wei et al.
ONCOTARGET (2015)
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
Petra Heffeter et al.
EUROPEAN JOURNAL OF CANCER (2013)
Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis
Bee-Jen Tan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
AKT Kinase Pathway: A Leading Target in Cancer Research
Ambuj Kumar et al.
SCIENTIFIC WORLD JOURNAL (2013)
Regorafenib for cancer
Dirk Strumberg et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Danli Wu et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Ruthenium Polypyridyl Complexes That Induce Mitochondria-Mediated Apoptosis in Cancer Cells
Tianfeng Chen et al.
INORGANIC CHEMISTRY (2010)
A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP
Xiangjun Meng et al.
CANCER RESEARCH (2009)
Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
Tina M. Thornton et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2009)
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Analysis of apoptosis by propidium iodide staining and flow cytometry
Carlo Riccardi et al.
NATURE PROTOCOLS (2006)
The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells
S Kapitza et al.
CANCER LETTERS (2005)
Antioxidants and oxidants regulated signal transduction pathways
ED Owuor et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Share Paper
